Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Mark Awad, MD, PhD

Medical Oncology

Make an Appointment
Watch Video

Mark Awad, MD, PhD


  • Director of Clinical Research
  • Program Director, Advanced Fellowship in Thoracic Oncology
  • Physician
  • Associate Professor of Medicine, Harvard Medical School


Clinical Interests

  • Immunotherapy
  • Lung cancer
  • Mesothelioma
  • Targeted therapies

Contact Information

  • Appointments877-332-4294 (new)
    617-632-6190 (established)
  • Office Phone Number617-632-3468
  • Fax617-632-5786


Dr. Mark Awad is an Associate Professor of Medicine at Harvard Medical School and Clinical Director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute. He received his undergraduate degree from Harvard University and his MD and PhD degrees from the Johns Hopkins School of Medicine. He completed his residency and chief residency at the Massachusetts General Hospital, and his medical oncology fellowship at the Dana-Farber Cancer Institute before joining the Dana-Farber faculty in 2014. His translational research focus is on identifying biomarkers of response and resistance to targeted therapies and immunotherapies in lung cancer. He is the principal investigator of several clinical trials for patients with thoracic malignancies and collaborates closely with laboratory-based investigators. His research has been published in journals such as the New England Journal of Medicine, the Journal of Clinical Oncology, Cancer Immunology Research, and the Journal of Thoracic Oncology. He is a recipient of the 2015 Young Investigator Award from the American Society of Clinical Oncology (ASCO), the 2015 Young Investigator Award from the International Association for the Society of Lung Cancer (IASLC), the 2017 Career Development Award from Conquer Cancer Foundation of ASCO, and the 2018 ALK Positive/LUNGevity Transformational Research Award.

Board Certification:

  • Internal Medicine, 2011
  • Medical Oncology, 2014


  • Dana-Farber/Partners CancerCare, Hematology/Oncology


  • Massachusetts General Hospital, Chief Resident, Internal Medicine
  • Massachusetts General Hospital, Internal Medicine

Medical School:

  • Johns Hopkins School of Medicine

Recent Awards:

  • Young Investigator Award (YIA), American Society of Clinical Oncology (ASCO) 2015
  • Young Investigator Award (YIA), International Association for the Study of Lung Cancer (IASLC) 2015
  • Lung Cancer Developmental Research Award, Dana-Farber / Harvard Cancer Center 2015
  • Koch Institute Expansion Bridge Grant Recipient 2016


Immunotherapies and Vaccine Development

Dr. Awad's main area of research is on cancer immunotherapy and vaccine development.  He has been working with a number of laboratories to study the genetics and immune microenvironment of lung tumors in order to develop better immune therapies for cancer patients.  In addition, he conducts research on cancers whose growth is driven by mutations in genes such as RET, ROS1, and ALK, and he has been working to understand how these cancers acquire resistance to targeted therapies.


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions